Riluzole has neuroprotective effects on Alzheimer’s disease in rat models, due to decreased acetylcholinesterase (AChE) activity and oxidative stress marker [61]. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.